Psoriatic Arthritis
📧 Sign up to get email alerts when something new happens for Psoriatic Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: 24 Week Efficacy and 3-year Safety and Efficacy of Secukinumab in Active Psoriatic Arthritis [Phase 3]
Phase 3 trial updates show 24-week efficacy and 3-year safety and efficacy data for secukinumab in active psoriatic arthritis.
-
CLINICAL_TRIALS trial_result · 2019-04-02Clinical Trial Update: A Study of Ixekizumab (LY2439821) Versus Adalimumab in Participants With Psoriatic Arthritis [Phase 4]
Phase 4 trial comparing ixekizumab to adalimumab in psoriatic arthritis completed with results posted.
-
FDA approval · 2019-03-21FDA Approved: ORENCIA — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
FDA approved a supplemental application for ORENCIA (abatacept) submitted by E.R. Squibb & Sons, L.L.C., indicating a labeling change and/or…
-
EMA withdrawal · 2019-03-06EMA Withdrawn: Cyltezo (adalimumab) — Boehringer Ingelheim International GmbH
The EMA withdrew Cyltezo (adalimumab) from Boehringer Ingelheim International GmbH, affecting multiple indications including hidradenitis su…
-
EMA withdrawal · 2019-03-05EMA Withdrawn: Solymbic (adalimumab) — Amgen Europe B.V.
Solymbic (adalimumab) has been withdrawn from the market by Amgen Europe B.V.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-02-22Clinical Trial Update: Etanercept and Methotrexate in Combination or as Monotherapy in Psoriatic Arthritis [Phase 3]
Phase 3 trial assessing etanercept, alone or with methotrexate, for psoriatic arthritis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-02-01Clinical Trial Update: Assessment of Tender & Swollen Joints Count Score Performed by a Rheumatologist And Rheumatology Nurses in Patients With RA and PsA.
This clinical trial update describes the assessment of a Tender and Swollen Joints Count Score performed by rheumatologists and rheumatology…
-
FDA label_change · 2019-01-29FDA Approved: TREMFYA — Supplemental Application (Janssen Biotech, Inc.)
FDA approved a supplemental application for TREMFYA (guselkumab) by Janssen Biotech, Inc., resulting in changes to the labeling.
-
CLINICAL_TRIALS trial_result · 2019-01-28Clinical Trial Update: Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn's Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical Practice
This clinical trial update reports on patient adherence attitudes toward scheduled adalimumab maintenance therapy across multiple inflammato…
-
CLINICAL_TRIALS trial_result · 2019-01-09Clinical Trial Update: Study in Ankylosing Spondylitis (AS) and Psoriatic Arthritis (PsA) Patients to Evaluate Work Productivity Before and After the Start of Adalimumab Therapy in Daily Practice in Belgium
Completed clinical trial assessing work productivity in Ankylosing Spondylitis and Psoriatic Arthritis patients before and after starting ad…
-
CLINICAL_TRIALS trial_result · 2018-11-26Clinical Trial Update: Initial Treatment With Golimumab in Early PsA [Phase 3]
Phase 3 trial updating initial treatment with golimumab in early psoriatic arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2018-10-31Clinical Trial Update: Study to Assess the Injection Site Pain Associated With a New Etanercept Formulation in Adults With Rheumatoid Arthritis or Psoriatic Arthritis [Phase 3]
Phase 3 clinical trial update evaluating injection site pain with a new etanercept formulation in adults with rheumatoid arthritis or psoria…
-
FDA approval · 2018-10-30FDA Approved: ADALIMUMAB — Original Application (Sandoz Inc)
FDA approved the original application for the adalimumab biosimilar ADALIMUMAB-ADAZ from Sandoz Inc. The approval covers the same indication…
-
FDA approval · 2018-10-16FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
FDA approved a supplemental application for Humira (adalimumab) submitted by Cordavis Limited.
-
CLINICAL_TRIALS trial_result · 2018-10-16Clinical Trial Update: Special Investigation in Patients With Psoriatic Arthritis (PsA) (Working Productivity and Activity Impairment [WPAI])
A completed clinical trial assessing working productivity and activity impairment in patients with psoriatic arthritis; results posted in 20…
-
FDA approval · 2018-10-03FDA Approved: ENBREL — Supplemental Application (Immunex Corporation)
FDA approved a supplemental application for Enbrel (etanercept) submitted by Immunex Corporation. The approval updates the labeling as descr…
-
CLINICAL_TRIALS research · 2018-07-23Clinical Trial Update: Fertility Study of Women With Chronic Inflammatory Rheumatism
This clinical trial update describes a fertility study in women with chronic inflammatory rheumatism, including psoriatic arthritis, rheumat…
-
CLINICAL_TRIALS trial_result · 2018-07-19Clinical Trial Update: Vascular Effects of Achieving Minimal Disease Activity in Psoriatic Arthritis - a 2 Year Prospective Cohort Study [NA]
This completed two-year prospective cohort study from the Chinese University of Hong Kong examines whether achieving minimal disease activit…
-
CLINICAL_TRIALS research · 2018-06-21Clinical Trial Update: Mechanism of Action of Ustekinumab in Psoriatic Arthritis
Clinical trial update on the mechanism of action of ustekinumab in psoriatic arthritis. No clinical results are provided.
-
FDA approval · 2018-06-08FDA Approved: USTEKINUMAB — Supplemental Application (Janssen Biotech, Inc.)
FDA approved a supplemental application for ustekinumab submitted by Janssen Biotech, Inc.
-
FDA approval · 2018-05-25FDA Approved: ENBREL — Supplemental Application (Immunex Corporation)
FDA approved a supplemental application for ENBREL (etanercept) submitted by Immunex Corporation. The approval pertains to the supplement to…
-
FDA approval · 2018-05-11FDA Approved: ENBREL — Supplemental Application (Immunex Corporation)
The FDA approved a supplemental application for ENBREL (etanercept) submitted by Immunex Corporation. The action updates the drug's labeling…
-
CLINICAL_TRIALS trial_result · 2018-04-23Clinical Trial Update: A Study to Assess Efficacy and Safety of Filgotinib in Active Psoriatic Arthritis [Phase 2]
Phase 2 study of filgotinib in active psoriatic arthritis has completed. The trial collected efficacy and safety data.
-
CLINICAL_TRIALS trial_result · 2018-04-17Clinical Trial Update: Predicting Hospitalized Infection in Patients With Chronic Inflammatory Arthritis Treated With Biological Drugs
This completed study investigates predictors of hospitalization due to infection in patients with rheumatoid arthritis, spondyloarthritis, o…
-
CLINICAL_TRIALS trial_result · 2018-04-05Clinical Trial Update: Genetic Analysis of Psoriasis and Psoriatic Arthritis
A completed clinical trial funded by the National Cancer Institute reports genetic analysis findings related to psoriasis and psoriatic arth…